Plazomicin is a next-generation aminoglycoside that has been designed as an antibiotic to avoid resistance through aminoglycoside-modifying enzymes. Plazomicin demonstrates high activity against the Enterobacteriaceae including extended spectrum beta lactamase and most carbapenemase producers, and can be useful in treating complicated urinary tract infections (cUTIs) and acute pyelonephritis. It is undergoing Phase III clinical studies.
Ma, Shutao; Cai, Xiaokang. Method for preparing plazomicin antibiotic for bacterial infection. Assignee Shandong University, Peop. Rep. China. CN 108948107. (2018).
Aggen, James B.; Armstrong, Eliana S.; Goldblum, Adam A.; Dozzo, Paola; Linsell, Martin S.; Gliedt, Micah J.; Hildebrandt, Darin J.; Feeney, Lee Ann; Kubo, Aya; Matias, Rowena D.; Lopez, Sara; Gomez, Marcela; Wlasichuk, Kenneth B.; Diokno, Raymond; Miller, George H.; Moser, Heinz E. Synthesis and spectrum of the neoglycoside ACHN-490. Antimicrobial Agents and Chemotherapy. Volume 54. Issue 11. Pages 4636-4642. Journal. (2010).
